Culver City, CA, United States of America

Anders Eliasen

This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignees: Indi Molecular, Inc., Regeneron Pharmaceuticals, Inc.. Active years: 2023-2025.

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Location History:

  • Los Angeles, CA (US) (2023)
  • Culver City, CA (US) (2023 - 2024)

Company Filing History:


Years Active: 2023-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anders Eliasen

Introduction

Anders Eliasen is a notable inventor based in Culver City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel compounds and methods for medical applications. With a total of 4 patents to his name, Eliasen's work has the potential to impact various therapeutic areas.

Latest Patents

Eliasen's latest patents include groundbreaking research on compositions and methods relating to the detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (IDO1). This application provides stable heterobiligands made up of peptide-based IDO1 ligands and small molecule inhibitors of IDO1. The methods of use for these heterobiligands encompass detection, imaging, diagnostics, and therapeutic applications. Additionally, he has developed peptide libraries featuring non-canonical amino acids, which serve as protein binding agents. These libraries can be utilized to screen and select improved and more specific protein binding agents, enhancing the pharmaceutical landscape.

Career Highlights

Throughout his career, Anders Eliasen has worked with prominent companies in the biotechnology sector, including Indi Molecular, Inc. and Regeneron Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to innovative projects that advance medical science.

Collaborations

Eliasen has collaborated with talented individuals in his field, including Heather Dawn Agnew and Bert Tsunyin Lai. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of cutting-edge technologies.

Conclusion

Anders Eliasen's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical research and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…